Drug & medication recalls Moderate risk

Estradiol -triene-3 recalled over manufacturing violations

Recall date
April 13, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Spectrum Laboratory Products, Inc. recalls Estradiol (17-B-Estradiol; Estra-1,3,5(10)-triene-3, 17B-diol; Oestradiol) Plant Base, Micronized, U.S.P active pharmac…
Recall number
D-0881-2017
FDA classification
Class II
Brand / firm
Spectrum Laboratory Products, Inc.
Sold / distributed
Nationwide in the USA

Why it was recalled

CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Estradiol (17-B-Estradiol; Estra-1,3,5(10)-triene-3, 17B-diol; Oestradiol) Plant Base, Micronized, U.S.P active pharmaceutical ingredient, packaged in 1g, 5g, 25g, 6 x 25g, and 100g containers, Rx only, Spectrum Chemical Mfg. Corp, Gardena, CA 90248, New Brunswick, NJ 08901, Product code E1435.

Get recall alerts

Free email alert whenever Spectrum Laboratory Products, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Spectrum Laboratory Products, Inc.